Wednesday, 27 June 2018

Array's melanoma combo treatment wins FDA approval

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it had approved Array BioPharma Inc's combination treatment for use in patients with the deadliest form of skin cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)